BNET Industries
Last Fiscal Year Sales:$45.0M
- Public
- US
Dow Jones Description
Zila, Inc., headquartered in Phoenix, Arizona, is a diagnostic company dedicated to the prevention, detection and treatment of oral cancer and periodontal disease. In this report, Zila, the Company, we, us, or our refers to Zila, Inc. and its wholly-owned subsidiaries. Zila, Inc. is a holding company that conducted its business operations during fiscal 2008 through its wholly-owned subsidiaries: Zila Pharmaceuticals, Inc., Professional Dental Technologies, Inc. (Pro-Dentec), Zila Biotechnology, Inc., Zila Technical, Inc., Zila Limited (a United Kingdom company) and Ryker Dental of Kentucky, Inc. (inactive). We manufacture and market ViziLite ® Plus with TBlue ® (ViziLite ® Plus), our flagship product for the early detection of oral abnormalities that could lead to cancer. ViziLite ® Plus is an adjunctive medical device cleared by the FDA for use in a population at increased risk for oral cancer. In addition, Zila designs, manufactures and markets a suite of proprietary products sold exclusively and directly to dental professionals for periodontal disease, including the Rotadent ® Professional Powered Brush, the Pro-Select Platinum ® ultrasonic scaler and a portfolio of oral pharmaceutical products for both in-office and home-care use. All of our products are marketed and sold in the United States and Canada primarily through our direct field sales force and telemarketing organization. ...
Interim Chief Executive Officer
David R. BethuneNumber of Employees 367
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Zila Reports Fiscal 2009 Third Quarter Financial Results
-
Zila Reports 2Q Financial Results
-
Zila to Introduce ViziLite Plus in India
-
OTCPicks.com: ZILA is on the Move, be sure itaEURTMs on your Radar aEUR" An OTCPicks.com...
-
Zila Reports Fiscal 2009 First Quarter Financial Results
-
Zila Names Wade Brooksby to Board of Directors
-
Zila Reports Fiscal 2008 Fourth Quarter and Full Year Results
-
Zila avoids delisting, hires strategic adviser
News & Analysis
Filter by
company and zila inc. - All News and Analysis
Zila Requests NASDAQ Investigation
PHOENIX -- Zila, Inc. (Nasdaq:ZILAD) today announced that, as a result of suspicious end-of-day trading in the Company's stock during the past several weeks, the Company has made an urgent request that NASDAQ undertake an investigation to determine the reasons for this activity. About Zila, Inc. Zila, Inc.,...
Zila, Inc. to Announce Fiscal 2005 Second Quarter Results on Wednesday, March 9, 2005
PHOENIX -- Zila, Inc. (Nasdaq:ZILA) will release financial results for the fiscal 2005 second-quarter ended January 31, 2005, at the market close on Wednesday, March 9, 2005. The Company will also hold a teleconference to review the Company's financial results and strategic outlook.
Zila to Restate Financial Results
Business Editors, Health/Medical Writers PHOENIX--BUSINESS WIRE--Oct. 24, 2002 Zila, Inc. (Nasdaq:ZILA) today announced that it will restate its financial results for previous fiscal periods in response to requests and comments from the U.S. Securities and Exchange Commission SEC on its accounting for certain transactions. The restatements will...
MEDE AMERICA to Handle All Electronic Claims Processing for PracticeWorks
EAST MEADOW, N.Y.--BW HealthWire--March 25, 1999--MEDE AMERICA (Nasdaq: MEDE), a leading provider of integrated EDI Solutions to the healthcare industry, today announced an exclusive agreement with PracticeWorks to handle all of the company's electronic claims processing. PracticeWorks, a division of Zila Inc. (Nasdaq: ZILA), is one of the largest practice...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| David R. Bethune | Interim Chief Executive Officer |
| Andrew A. Stevens | CFO & Vice President |
| Frank J. Bellizzi | Executive Vice President, Business Development |
| Betty Pecha | Vice President, Legal |
| Diane E Klein | Vice President and Treasurer |
| G. Warren Chane | Vice President, Corp Business Development |
| Gary V. Klinefelter | See Remarks |
| George Heiler | Vice President, Manufacturing Operations |
| David A Barshis | Senior Vice President, General Manager, Zila Pharma |
| Charles Shively | Director, Product Development |
| Yu Ping Maguire | Head, Clinical & Regulatory Affairs |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Christopher D. Johnson | Board of Directors |
| George J Vuturo | Board of Directors |
| J Steven Garrett | Board of Directors |
| Jon M. Plexico | Board of Directors |
| Leslie Green | Board of Directors |
| O.B. Parrish | Board of Directors |
| Wade F Brooksby | Board of Directors |
Mr. Bethune has served as our Executive Chairman since August 2007. He has been a member of the board since 2005 and was appointed chairman on May 21, 2007. He is also a member of the Board of Cambrex Corporation. From 1999 until his retirement, he was Chairman and Chief Executive Officer of Atrix Laboratories, a drug delivery and product development company. Prior to Atrix Laboratories, he was President and Chief Operating Officer of IVAX Corporation, a pharmaceutical company. Before joining IVAX, Mr. Bethune began a start-up pharmaceutical company venture formed by Mayo Medical Ventures, a business unit of Mayo Clinics of Rochester. Mr. Bethune previously served as group vice president of American Cyanamid Company and a member of the Executive Committee where he had executive authority for human biologicals, consumer health products, pharmaceuticals and ophthalmics as well as global medical research. He was also President of the Lederle Laboratories Division of American Cyanamid Company. Mr. Bethune received a B.A. degree in accounting and economics from Lenior-Rhyne College, Hickory, North Carolina and Masters in Business Administration in the Executive Program from Columbia University Graduate School.
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Interim Chief Executive Officer | Current |
| Arnall Golden & Gregory, Llp | Current | |
| Zila, Inc. | Chairman | Current |
| The Female Health Company | Board of Directors | Current |
| Cambrex Corporation | Board of Directors | Current |
| The Female Health Company | Chairman & CEO | Former |
| American Cyanamid Company | President | Former |
| IVAX Corporation | Chief Operating Officer | Former |
| American Cyanamid Company | Group Vice President | Former |
| Zila, Inc. | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | CFO & Vice President | Current |
| Arnall Golden & Gregory, Llp | Current | |
| AMERCO | Chief Financial Officer | Former |
| CSK Auto Inc. | Vice President, Finance and Controller | Former |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Executive Vice President, Business Development | Current |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Vice President, Legal | Current |
Vice President and Treasurer since June 2004. Ms. Klein joined ZILA in August 2003 as Director of Finance. Ms. Klein was Vice President-Finance for Bay Area Foods, Inc., a privately held grocery chain, from 1998 to 2003. Prior to Bay Area Foods, Ms. Klein held progressively responsible financial/accounting positions at Southwest Supermarkets, LLC, MegaFoods Stores, Inc. and the Circle K Corporation. She was previously a senior manager in the audit practice of Arthur Andersen & Co. in Phoenix, AZ.
| Organization | Position | Status |
|---|---|---|
| Ce Space, LLC | Vice President and Treasurer | Current |
| Zila, Inc. | Vice President and Treasurer | Current |
| Zila, Inc. | Director of Finance | Current |
| Ce Space, LLC | Director of Finance | Former |
| Circle K | Former |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Vice President, Corp Business Development | Current |
Gary Klinefelter has served as Zila's Vice President and General Counsel since December 2004. Mr. Klinefelter was appointed ZILA's Secretary in October 2005. From 1988-2004, he was Secretary and General Counsel of AMERCO, a holding company whose principal operating subsidiaries are U-Haul International, Inc., Republic Western Insurance Company and Oxford Life Insurance Company. Mr. Klinefelter is licensed as an attorney in Arizona.
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Vice President and General Counsel | Current |
| Professional Dental Technologies, Inc. | Vice President and General Counsel | Current |
| Zila, Inc. | See Remarks | Current |
| Arnall Golden & Gregory, Llp | Current | |
| Republic Western Insurance Company | Principal | Former |
| Oxford Life Insurance Company | Principal | Former |
| U-Haul International, Inc. | Principal | Former |
| AMERCO | Secretary and General Counsel | Former |
| AMERCO | Secretary | Former |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Vice President, Manufacturing Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Senior Vice President, General Manager, Zila Pharma | Current |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Director, Product Development | Current |
| Zila, Inc. | Director, Product Development | Former |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Head, Clinical & Regulatory Affairs | Current |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Board of Directors | Current |
Dr. Vuturo, 57, has over 28 years of experience in the pharmaceuticals industry and is recognized as a leader in the field of medical education technology. In 1995, Dr. Vuturo founded Designing Solutions, L.L.C. and Professional Education Services Group, L.L.C., both are healthcare services companies that specialize in providing professional medical education programs to physicians, pharmacists, dentists, nurses, and other healthcare providers. Dr. Vuturo has served as managing partner of both companies since their inception. From 2004 to 2005, Dr. Vuturo was a member of the Board of Directors of QLT, Inc., a publicly-traded biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies. From 2001 to 2004, Dr. Vuturo was a member of the Board of Directors and, at various times, served on the Executive, Compensation, Audit and Nominations Committees of Atrix Laboratories, Inc. Atrix Laboratories, a former publicly-traded specialty pharmaceutical company, is focused on advanced drug delivery. In 2005, Atrix Laboratories merged with QLT, Inc. Dr. Vuturo received his Ph.D. in Health Care Administration from the University of Florida , where he also received his Bachelor of Science in Pharmacy. Additionally, Dr. Vuturo holds a B.S. in Biology from Fairfield University .
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Board of Directors | Current |
| Professional Dental Technologies, Inc. | Board of Directors | Current |
| QLT, Inc. | Board of Directors | Former |
| University of Florida | Ph.D. In Health Care Administration | Former |
| Fairfield University | B.S. In Biology | Former |
| Organization | Position | Status |
|---|---|---|
| Tolmar Inc. | Vice President of Clinical Development | Current |
| Professional Dental Technologies, Inc. | Board of Directors | Current |
| Zila, Inc. | Board of Directors | Current |
| Loma Linda University | Chairman | Former |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Board of Directors | Current |
| Merriman Curhan Ford & Co. | Vice President, Healthcare | Former |
| Merriman Curhan Ford & Co. | Managing Director, Healthcare | Former |
| Quidel Corporation | National Sales Manager, Autoimmune & Complement Division | Former |
| Colgate University | B.A., Political Science | Former |
| Organization | Position | Status |
|---|---|---|
| Green Inc. | Managing Partner | Current |
| Roffe & Green, Inc | Current | |
| Arnall Golden & Gregory, Llp | Current | |
| Professional Dental Technologies, Inc. | Board of Directors | Current |
| Zila, Inc. | Board of Directors | Current |
| Ssoe, Inc. | Board of Directors | Current |
| Nydic | Chief Executive Officer | Former |
| Nydic | President | Former |
| Swiss Army Brands, Inc. | Vice President, New Business Development and Strategic Planning | Former |
| Zila, Inc. | General Manager and interim National Sales Manager | Former |
| American Home Products Corporation | Marketing Manager | Former |
| Zila, Inc. | Interim National Sales Manager | Former |
| Marine Midland Bank | Marketing Manager | Former |
| Citicorp | Former |
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Board of Directors | Current |
| The Female Health Company | Chairman & CEO | Former |
Mr. Brooksby is currently chief financial officer of InNexus Biotechnical, Inc., a Toronto Stock Exchange traded drug development company. From 2004-2006, he was CFO of Energy West, Inc., a NASDAQ traded energy utility. Earlier, Mr. Brooksby served in senior level executive positions for several companies in a variety of industries. He has served as an energy-marketing advisor to the Governor of Kentucky and on the board of directors of nine public and private companies as well as two not-for-profit organizations. Mr. Brooksby earned a bachelor of science degree in accounting and a masters degree in accounting from Brigham Young University. Age 62
| Organization | Position | Status |
|---|---|---|
| Zila, Inc. | Board of Directors | Current |
Industry Transcripts by Seeking Alpha
-
Schiff Nutrition International, Inc. F3Q10 (Qtr End 02/28/10) Earnings Call Transcript
on Mar 17, 2010about WNI
-
XOMA Ltd. Q4 2009 Earnings Call Transcript
on Mar 11, 2010about XOMA
-
Peregrine Pharmaceuticals, Inc. F3Q10 (Qtr End 01/31/10) Earnings Call Transcript
on Mar 11, 2010about PPHM
-
Mannatech, Incorporated Q4 2009 Earnings Call Transcript
on Mar 11, 2010about MTEX
-
Chelsea Therapeutics International, Ltd. Q4 2009 Earnings Call Transcript
on Mar 10, 2010about CHTP
IndustryTop Rated
- Efficacy of Roche's Flu Drug Tamiflu In Doubt 3 votes
- The 5 Worst Drug Companies of 2009 3 votes
- If Approved -- FDA Drug Labeling Could Decide Ultimate Success of MannKind's Afrezza 3 votes
- 2010 FDA Approvals Could Lead to Launch of Eight Blockbuster Biotech Drugs 3 votes
- Dumbest PowerPoint Ever? J&J's P&L Slideshow of Alleged Kickback Scheme 2 votes


